Sponsor

UNITAID

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name UNITAID appears in 22 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials22
Recruiting shown1
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

22 shown
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesNCT06395129 · collaborator · 2024-09-13
RECRUITING
Pharmacokinetics and Safety of DolutegravIr in NeonateNCT05590325 · collaborator · 2022-09-12
UNKNOWN
CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme CareNCT05502692 · collaborator · 2022-07-12
COMPLETED
INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and KenyaNCT05382130 · collaborator · 2022-05-17
COMPLETED
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and KenyaNCT05498727 · collaborator · 2022-05-02
COMPLETED
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB TrialNCT04494516 · collaborator · 2021-06-04
COMPLETED
Inflammation and Co-Infections in D²EFTNCT04183738 · collaborator · 2021-02-01
WITHDRAWN
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited SettingsNCT04371835 · collaborator · 2020-08-12
COMPLETED
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)NCT04121026 · collaborator · 2019-10-02
COMPLETED
Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric FormulationNCT03836833 · collaborator · 2019-06-04
UNKNOWN
A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])NCT03541382 · collaborator · 2018-10-08
COMPLETED
Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index ClientsNCT03705611 · collaborator · 2018-09-12
UNKNOWN
Dolutegravir in Pregnant HIV Mothers and Their NeonatesNCT03249181 · collaborator · 2018-01-22
COMPLETED
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In ZimbabweNCT04206241 · collaborator · 2018-01-01
COMPLETED
Dolutegravir and Darunavir Evaluation in Adults Failing TherapyNCT03017872 · collaborator · 2017-11-23
UNKNOWN
Impact of Point-of-Care EID for HIV-Exposed InfantsNCT03824067 · collaborator · 2017-08-01
COMPLETED
Evaluating the Feasibility of Point of Care Birth Testing in EswatiniNCT04206878 · collaborator · 2017-06-01
COMPLETED
Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited SettingsNCT02777229 · collaborator · 2016-07-01
COMPLETED
HIV Self-Testing Africa ZambiaNCT02793804 · collaborator · 2016-06-01
COMPLETED
HIV Self-Testing Africa (STAR) Malawi: General PopulationNCT02718274 · collaborator · 2016-04-01
COMPLETED
Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)NCT02346487 · collaborator · 2015-09-01
COMPLETED
Early Infant Diagnosis Point of Care PilotNCT02634450 · collaborator · 2015-09-01
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing UNITAID as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
dolutegravir4
darunavir2
ritonavir2
dolutegravir 50 MG1
efavirenz 400 MG1
dolutegravir RxCUI 1433868 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 4 trials darunavir RxCUI 460132 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials ritonavir RxCUI 85762 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials dolutegravir 50 MG RxCUI 1433869 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial efavirenz 400 MG RxCUI 2001423 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator22
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.